NETEC Resource Library

The Special Pathogens Research Network: Enabling Research Readiness

Elemento

Click for External Resource*


*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.


Item Type

Publicación

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Was this resource helpful?


Título

The Special Pathogens Research Network: Enabling Research Readiness

Materia

Descripción

The 2013-2016 epidemic of Ebola virus disease (EVD) that originated in West Africa underscored many of the challenges to conducting clinical research during an ongoing infectious disease epidemic, both in the most affected countries of Guinea, Liberia, and Sierra Leone, as well as in the United States and Europe, where a total of 27 patients with EVD received care in biocontainment units.

Fecha

2019-02-19

Citación

Kraft, Colleen S., Mark G. Kortepeter, Bruce Gordon, Lauren M. Sauer, Erica S. Shenoy, Daniel P. Eiras, LuAnn Larson, Jennifer A. Garland, Aneesh K. Mehta, Kevin Barrett, Connie S. Price, Caroline Croyle, Lauren R. West, Brooke Noren, Susan Kline, Christa Arguinchona, Henry Arguinchona, Jonathan D. Grein, Chad Connally, Susan McLellan, George F. Risi, Timothy M. Uyeki, Richard T. Davey, Jo Ellen Schweinle, Michelle M. Schwedhelm, Melissa Harvey, Richard C. Hunt, and Christopher J. Kratochvil. 2019. "The Special Pathogens Research Network: Enabling Research Readiness." Health security 17 (1):35-45.

Resumen

Abstract

The 2013-2016 epidemic of Ebola virus disease (EVD) that originated in West Africa underscored many of the challenges to conducting clinical research during an ongoing infectious disease epidemic, both in the most affected countries of Guinea, Liberia, and Sierra Leone, as well as in the United States and Europe, where a total of 27 patients with EVD received care in biocontainment units. The Special Pathogens Research Network (SPRN) was established in the United States in November 2016 to provide an organizational structure to leverage the expertise of the 10 Regional Ebola and Other Special Pathogen Treatment Centers (RESPTCs); it was intended to develop and support infrastructure to improve readiness to conduct clinical research in the United States. The network enables the rapid activation and coordination of clinical research in the event of an epidemic and facilitates opportunities for multicenter research when the RESPTCs are actively caring for patients requiring a biocontainment unit. Here we provide an overview of opportunities identified in the clinical research infrastructure during the West Africa EVD epidemic and the SPRN activities to meet the ongoing challenges in the context of Ebola virus and other special pathogens.

The 2013-2016 epidemic of Ebola virus disease (EVD) that originated in West Africa underscored many of the challenges to conducting clinical research during an ongoing infectious disease epidemic. The authors provide an overview of opportunities identified in the clinical research infrastructure during the West Africa EVD epidemic and the Special Pathogens Research Network activities to meet the ongoing challenges in the context of Ebola virus and other special pathogens.

Accesibilidad

Free online

Collection